Search by Drug Name or NDC

    NDC 00591-0745-01 Estazolam 2 mg/1 Details

    Estazolam 2 mg/1

    Estazolam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is ESTAZOLAM.

    Product Information

    NDC 00591-0745
    Product ID 0591-0745_b25f02d6-4a96-479e-9399-30dde39b1f03
    Associated GPIs 60201005000320
    GCN Sequence Number 015604
    GCN Sequence Number Description estazolam TABLET 2 MG ORAL
    HIC3 H21
    HIC3 Description SEDATIVE-HYPNOTICS - BENZODIAZEPINES
    GCN 19182
    HICL Sequence Number 006036
    HICL Sequence Number Description ESTAZOLAM
    Brand/Generic Generic
    Proprietary Name Estazolam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Estazolam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name ESTAZOLAM
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA074818
    Listing Certified Through 2024-12-31

    Package

    NDC 00591-0745-01 (00591074501)

    NDC Package Code 0591-0745-01
    Billing NDC 00591074501
    Package 100 TABLET in 1 BOTTLE, PLASTIC (0591-0745-01)
    Marketing Start Date 1997-10-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.7987
    Pricing Unit EA
    Effective Date 2023-09-20
    NDC Description ESTAZOLAM 2 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis